As a private practitioner in hematology, oncology, and internal medicine for 20 years, Robert Dean Stebbins, MD, specialized in the treatment of breast cancer and leukemia. At his solo private practice in Palo Alto, California, he also provided oncologic and internal medicine consultation for corporate executives from around the world. Robert Dean Stebbins, MD, taught at Stanford University School of Medicine for two decades as well, rising to the distinguished position of Clinical Professor of Medicine. In other professional pursuits, he served as Associate Director of the Compromised Host Unit at Stanford University, which treats leukemia patients. Dr. Stebbins’ lengthy relationship with Stanford University’s medical program includes memberships on the Stanford University Hospital Medical Board, Technology Transfer Committee, and the Hospital Board Subcommittee on Managed Care. Dr. Robert D. Stebbins, also chaired the Committee on Voluntary Cost Containment and acted as Deputy Chief of the Medical Serviceat the hospital. In the Deepartment of Medicine at Stanford University School of Medicine, Robert Dean Stebbins, MD, joined the Intern Selection Committee and became Chairman of the Committee on Residency Training and Clinical Service. In addition, he established the Private Physicians Group at Stanford, Inc. Over more than two decades, Robert Dean Stebbins, MD, co-authored numerous scientific articles, such as “Megaloblastic Anaemia Produced by Drugs” in Clinical Haematology and “Adjunctive Chemotherapy” in Cancer: A Comprehensive Treatise, Volume 1, Etiology: Chemical and Physical Carcinogenesis. He also contributed to “Transvenous Biopsy of mediastinal lymphoma invading the superior vena cava” in Catheterization and Cardiovascular Diagnosis. In addition, Dr. Stebbins co-wrote pieces published in Science, Archives of Biochemistry and Biophysics, the Journal of Biological Chemistry, and several other professional journals and books.